United States · FDA National Drug Code directory
BENDAMUSTINE HYDROCHLORIDE
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 10019-079_007f13c9-9ca3-45f9-bbae-6806681efd06
- Product NDC
- 10019-079
- Form
- INJECTION
- Composition / generic term
- bendamustine hydrochloride
- Labeler
- Baxter Healthcare Corporation
- Marketing category
- NDA
- Marketing start / end (source format)
- 20221215
- Source listing expiry
- 20271231
Source-listed ingredients
- BENDAMUSTINE HYDROCHLORIDE — 100 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 1 VIAL, MULTI-DOSE in 1 CARTON (10019-079-01) / 1 INJECTION in 1 VIAL, MULTI-DOSE · 10019-079-01
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →